The role of platelets in diabetes-related vascular complications.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  2000-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0168-8227(00)00160-1PMID 10936664
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet Factor 4

  2020cited by this paper
• Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.

  2003cited by this paper
• Aspirin therapy in diabetes.

  2000cited by this paper
• Vitamin E supplementation and cardiovascular events in high-risk patients.

  2000cited by this paper
• Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-53.

  2000cited by this paper
• Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting.

  1999cited by this paper
• Do determinants of platelet function co-segregate with genetic markers of type 1 diabetes mellitus?

  1999cited by this paper
• PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement.

  1999cited by this paper
• Possible mechanisms of the altered platelet volume distribution in type 2 diabetes: does increased platelet activation contribute to platelet size heterogeneity?

  1999cited by this paper
• Incidence and Clinical Course of Thrombotic Thrombocytopenic Purpura Due to Ticlopidine Following Coronary Stenting

  1999cited by this paper
• Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.

  1999cited by this paper
• Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

  1998influential reference
• Effect of camonagrel, a selective thromboxane synthase inhibitor, on retinal vascularization in experimental diabetes.

  1998cited by this paper
• Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.

  1998cited by this paper
• Randomised placebo-controlled and balloon-angioplasty- controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade

  1998cited by this paper
• Platelet Resistance to Nitrates in Obesity and Obese NIDDM, and Normal Platelet Sensitivity to Both Insulin and Nitrates in Lean NIDDM

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

  1998cited by this paper
• Endothelial integrity, soluble adhesion molecules and platelet markers in Type 1 diabetes mellitus

  1998cited by this paper
• Endothelial function in health and disease: new insights into the genesis of cardiovascular disease.

  1998cited by this paper
• Inherited platelet glycoprotein polymorphisms and a risk for coronary heart disease in young central Europeans.

  1998cited by this paper
• Relationship of Blood Thromboxane-B2 (TxB2) With Lipid Peroxides and Effect of Vitamin E and Placebo Supplementation on TxB2 and Lipid Peroxide Levels in Type 1 Diabetic Patients

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• Platelet cNOS Activity Is Reduced in Patients with IDDM and NIDDM

  1998cited by this paper
• Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade.

  1998cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Decreased nitric oxide synthase activity in platelets from IDDM and NIDDM patients

  1998cited by this paper
• Platelet membrane lipid fluidity and intraplatelet calcium mobilization in type 2 diabetes mellitus

  1998cited by this paper
• Platelet activation in diabetic microangiopathy.

  1998cited by this paper
• Shear-induced platelet adhesion and aggregation on subendothelium are increased in diabetic patients.

  1998influential reference
• Polymorphisms of platelet glycoproteins in relation to macrovascular disease in Type 2 diabetes mellitus

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Polymorphism of the Platelet Glycoprotein IIIa Gene in Patients with Coronary Stenosis

  1998cited by this paper
• Soluble Adhesion Molecules in Type 1 Diabetes Mellitus

  1997influential reference
• The association of reduced endothelium derived relaxing factor-NO production with endothelial damage and increased in vivo platelet activation in patients with diabetes mellitus.

  1997cited by this paper
• Platelet adhesion and aggregation without endothelial denudation or exposure of basal lamina and/or collagen.

  1997cited by this paper
• Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis.

  1997cited by this paper
• Diabetes-induced alterations in platelet metabolism.

  1997cited by this paper
• Endothelial markers in diabetes mellitus.

  1997cited by this paper
• Structure and function of platelet alpha IIb beta 3.

  1997cited by this paper
• PIA1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis.

  1997cited by this paper
• Aspirin Therapy in Diabetes

  1997influential reference
• Vascular homeostasis, adhesion molecules, and macrovascular disease in non‐insulin‐dependent diabetes mellitus

  1997cited by this paper
• Phosphorylation of Myosin Light Chain in Resting Platelets From NIDDM Patients Is Enhanced: Correlation With Spontaneous Aggregation

  1997cited by this paper
• Glycemia and Regulation of Endothelial Adhesion Molecules

  1997cited by this paper
• Diabetic human platelets release a substance that inhibits platelet-mediated vasodilation.

  1997cited by this paper
• Increased Tissue Factor Pathway Inhibitor (TFPI) and Coagulation in Patients with Insulin-dependent Diabetes mellitus

  1997cited by this paper
• Effect of aspirin plus dipyridamole on the retinal vascular pattern in experimental diabetes mellitus.

  1997cited by this paper
• Activated platelets in subjects at increased risk of IDDM

  1997cited by this paper
• Altered Platelet Membrane Dynamic Properties in Type 1 Diabetes

  1997influential reference
• Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.

  1997cited by this paper
• Oxygen free radicals and platelet activation.

  1997cited by this paper
• Aspirin therapy in diabetes.

  1997cited by this paper
• E-Selectin plasma concentration is influenced by glycaemic control in NIDDM patients: possible role of oxidative stress

  1997cited by this paper
• Effect of insulin on blood rheology in non‐diabetic subjects and in patients with type 2 diabetes mellitus

  1997influential reference
• Platelet-leukocyte-cross-talk in diabetes mellitus.

  1997influential reference
• Increased intracellular calcium and altered phorbol dibutyrate binding to intact platelets in young subjects with insulin-dependent and non-insulin-dependent diabetes mellitus.

  1997cited by this paper
• Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients.

  1997cited by this paper
• Modulatory Effect of Erythrocytes on the Platelet Reactivity to Collagen in IDDM Patients

  1997cited by this paper
• New antiplatelet drugs.

  1997cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

  1996cited by this paper
• Atherosclerosis: risk factors and the vascular endothelium.

  1996cited by this paper
• Assessing the evidence on aspirin in diabetes mellitus. Gemini or Libra; lumping or splitting; surrogate or hard; low or high; interventionist or nihilist

  1996cited by this paper
• Antiplatelet therapy.

  1996cited by this paper
• A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

  1996cited by this paper
• Does reduced membrane lipid fluidity underlie the altered thrombin-induced expression of integrin α(IIb)β(3) and PADGEM-140 in membranes of platelets from diabetic juveniles?

  1996cited by this paper
• Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

  1996cited by this paper
• A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

  1996cited by this paper
• Diabetes Mellitus Alters the Effect of Peptide and Protein Ligands on Membrane Fluidity of Blood Platelets

  1996cited by this paper
• Thrombolytic action of ticlopidine: possible mechanisms.

  1996cited by this paper
• Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia.

  1996cited by this paper
• Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

  1996cited by this paper
• Platelet/polymorphonuclear leukocyte interaction in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the beta 2 integrin CD11b/CD18.

  1996cited by this paper
• Elevated Circulating P-Selectin in Insulin Dependent Diabetes Mellitus

  1996cited by this paper
• Cytosolic Ca2+ Content and Membrane Fluidity of Platelets and Polymorphonuclear Leucocytes in Diabetes Mellitus

  1995cited by this paper
• Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro.

  1995cited by this paper
• Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes.

  1995cited by this paper
• Thrombomodulin Levels in Insulin‐dependent Diabetic Patients with Microalbuminuria

  1995cited by this paper
• Release of Platelet Plasminogen Activator Inhibitor 1 in Whole Blood Is Increased in Patients With Type II Diabetes

  1995cited by this paper
• The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel--a new thromboxane synthase inhibitor.

  1995cited by this paper
• Modulation by high glucose of adhesion molecule expression in cultured endothelial cells

  1995cited by this paper
• The Activated Megakaryocyte-Platelet-System Vascular Disease: Focus on Diabetes

  1995cited by this paper
• A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2.

  1995cited by this paper
• Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

  1995cited by this paper
• Which diabetic patients should be taking aspirin?

  1995cited by this paper
• Exposure of Adhesion Molecules on Activated Platelets in Patients with Newly Diagnosed IDDM Is Not Normalized by Near-Normoglycemia

  1995cited by this paper
• Comparison of the effects of picotamide and aspirin on renal albumin excretion and cutaneous microcirculation in patients with type II diabetes mellitus: a pilot study

  1995cited by this paper
• Platelet factor 4, beta-thromboglobulin and thrombospondin levels in type I diabetes mellitus patients.

  1994cited by this paper
• Stabilization of platelet-fibrinogen interactions is an integral property of the glycoprotein IIb-IIIa complex.

  1994cited by this paper
• Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.

  1994cited by this paper
• Polymorphonuclear Leukocyte-Platelet Interaction: Role of P-Selectin in Thromboxane B2 and Leukotriene C4 Cooperative Synthesis

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Platelet Factor 4, β-Thromboglobulin and Thrombospondin Levels in Type I Diabetes Mellitus Patients

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy

  1994cited by this paper
• Increased plasma endothelin in diabetes: an atherosclerosis marker?

  1994cited by this paper
• Randomized Trial of Ridogrel, a Combined Thromboxane A2 Synthase Inhibitor and Thromboxane A2/Prostaglandin Endoperoxide Receptor Antagonist, Versus Aspirin as Adjunct to Thrombolysis in Patients With Acute Myocardial Infarction: The Ridogrel Versus Aspirin Patency Trial (RAPT)

  1994cited by this paper
• A functional integrin ligand on the surface of platelets: intercellular adhesion molecule-2.

  1994cited by this paper
• Platelet Plasminogen Activator Inhibitor 1 in Patients With Type II Diabetes

  1994cited by this paper
• Thrombinogenesis and its pharmacological modulation in atherosclerosis.

  1994cited by this paper

• Diabetic Platelets: Pathophysiology, Clinical Significance, and Therapeutic Perspectives

  2025cites this paper
• Hematological and Hemorheological Parameters of Blood Platelets as Biomarkers in Diabetes Mellitus Type 2: A Comprehensive Review

  2024cites this paper
• The association of platelet to white blood cell ratio with diabetes: a nationwide survey in China

  2024cites this paper
• Analysis of the Relationship Between Soluble Cd40 Ligand and Homeostasis Model Assessment of Insulin Resistance in Obese Non-Diabetic Subjects

  2024cites this paper
• Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidences.

  2023cites this paper
• Circulating platelet-neutrophil aggregates characterize the development of type 1 diabetes in humans and NOD mice

  2022cites this paper
• Cyperus esculentus L. and Tetracarpidium conophorum Müll. Arg. Supplemented Diet Improved Testosterone Levels, Modulated Ectonucleotidases and Adenosine Deaminase Activities in Platelets from L-NAME-Stressed Rats

  2021influential citation
• The relationship between hemoglobin A1c levels and thrombus load in patients with type 2 diabetes mellitus and non-ST-segment elevation myocardial infarction

  2021cites this paper
• Effect of advanced glycation end products on platelet activation and aggregation: a comparative study of the role of glyoxal and methylglyoxal

  2020cites this paper
• Platelet counts are associated with arterial stiffness in Chinese Han population: a longitudinal study

  2020cites this paper
• Influence of Cardiometabolic Risk Factors on Platelet Function

  2020cites this paper
• The Role of Platelets in Diabetes Mellitus

  2019cites this paper
• Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

  2019cites this paper
• Hypercholesterolemia impairs the Glucagon-like peptide 1 action on platelets: Effects of a lipid-lowering treatment with simvastatin.

  2019cites this paper
• Platelet Oxidative Stress and its Relationship with Cardiovascular Diseases in Type 2 Diabetes Mellitus Patients.

  2019cites this paper
• Measurement of Mean Platelet Volume and Platelet Distribution Width among Uncontrolled Type 2 Diabetic Sudanese Patients

  2019cites this paper
• The Relationship Between Mean Platelet Volume and Fasting Plasma Glucose and HbA1c Levels in a Large Cohort of Unselected Health Check-Up Participants

  2018cites this paper
• Mitochondrial Calcium In Diabetic Platelets: Friend Or Foe?

  2018influential citation
• Platelet oxidative stress and its relationship with cardiovascular diseases in type 2 diabetes mellitus patients.

  2017cites this paper
• Evaluation of Coagulation Profile in Children with Type 1 Diabetes Mellitus Using Rotational Thromboelastometry

  2017cites this paper
• Advanced non-alcoholic steatohepatitis cirrhosis: A high-risk population for pre-liver transplant portal vein thrombosis

  2017cites this paper
• Platelets and Diabetes

  2017cites this paper
• Hemostasis and anticoagulant therapy in liver diseases

  2017cites this paper
• Transient receptor potential canonical type 3 channels: Interactions, role and relevance - A vascular focus.

  2017cites this paper
• The Role of Yeast Beta Glucan on Blood Coagulation in Streptozotocin-Induced Diabetes and Irradiated Rats

  2016cites this paper
• Dietary Supplementation of Ginger and Turmeric Rhizomes Modulates Platelets Ectonucleotidase and Adenosine Deaminase Activities in Normotensive and Hypertensive Rats

  2016cites this paper
• Store-operated calcium entry and diabetic complications

  2016cites this paper
• Influence of genetic variations in platelet glycoproteins and eNOS in the development of arterial ischaemia of lower limbs in type 2 diabetes mellitus patients.

  2016cites this paper
• Medicinal Plants with Antiplatelet Activity

  2016cites this paper
• Altered Platelets’ morphological parameters in children with type 1 diabetes – a case-control study

  2015cites this paper
• Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus

  2015cites this paper
• Functional and physiopathological implications of TRP channels.

  2015cites this paper
• Signature biomarkers in Diabetes Mellitus and associated Cardiovascular diseases

  2015cites this paper
• Feasibility of Platelet Indices As Possible Biomarkers in Evaluation of Initial Vascular Risks in Diabetes Mellitus: Correlation of Platelet Dysfunction Indices With Hematopoietic and Biochemical Biomarkers in Non-diabetic Subjects

  2015cites this paper
• Platelet Aggregation Increased by Advanced Glycated Hemoglobin

  2015cites this paper
• Adenosine receptors and diabetes: Focus on the A(2B) adenosine receptor subtype.

  2015cites this paper
• Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease

  2015cites this paper
• Role of multiligand/RAGE axis in platelet activation.

  2014cites this paper
• High glucose enhances CD39 expression in vascular endothelial cells

  2014cites this paper
• A review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic risk.

  2014cites this paper
• Innate Immune Activity Is Detected Prior to Seroconversion in Children With HLA-Conferred Type 1 Diabetes Susceptibility

  2014cites this paper
• Assessment of spontaneous platelet aggregation using laser light scattering in healthy subjects: an attempt to standardize

  2014cites this paper
• Antidiabetic and Antiplatelet Aggregation Activities of Bridelia ndellensis Stem Bark Extracts

  2013cites this paper
• Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus

  2013cites this paper
• Mechanisms of cardiovascular disease in the metabolic syndrome and type 2 diabetes mellitus : focus on adverse intermediate phenotypes

  2013cites this paper
• Chapter 35 – Diabetes Mellitus

  2013cites this paper
• Impaired glucose metabolism and type 2 diabetes are associated with hypercoagulability: potential role of central adiposity and low-grade inflammation--the Hoorn Study.

  2012cites this paper
• Effect of antithrombotic drugs on platelet function and receptors and an investigation into platelet cholesterol

  2012cites this paper
• SOCE and Ca 2+ Handling in Platelet Dysfunction

  2012cites this paper
• Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.

  2012cites this paper
• Pharmacological Strategies to Reduce Cardiovascular Risk in Type 2 Diabetes Mellitus

  2012cites this paper
• UNIVERSIDAD NACIONAL DE CÓRDOBA FACULTAD DE CIENCIAS MÉDICAS Estudio del Síndrome Metabólico en la población de Bulnes. Consideración de nuevos aspectos.

  2012cites this paper
• The Effect of Combined C-Peptide and Zinc on Cellular Function

  2012cites this paper
• Ca2+ leakage rate from agonist-sensitive intracellular pools is altered in platelets from patients with type 2 diabetes

  2011cites this paper
• Inhibition of the formation of advanced glycation end products by thymoquinone.

  2011cites this paper
• Modulation of platelet function and signaling by flavonoids.

  2011cites this paper
• Attenuated store-operated divalent cation entry and association between STIM1, Orai1, hTRPC1 and hTRPC6 in platelets from type 2 diabetic patients.

  2011cites this paper
• Aspirin Responsiveness in Ischemic Stroke Patients in Relation to Diabetes Mellitus, Lipid and Hemostatic Profile* Odpowiedź na aspirynę w niedokrwiennym udarze mózgu w odniesieniu do cukrzycy, profilu lipidowego i profilu hemostazy

  2010cites this paper
• Metabolic and hemostatic characteristics of patients with type 2 diabetes mellitus differing in the severity of angiopathy

  2010cites this paper
• The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitus.

  2010cites this paper
• Homocysteine induces caspase activation by endoplasmic reticulum stress in platelets from type 2 diabetics and healthy donors

  2010cites this paper
• Role of Oxidant Scavengers in the Prevention of Ca2+ Homeostasis Disorders

  2010cites this paper
• Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.

  2010cites this paper
• Tweaking the gain on platelet regulation: the tachykinin connection.

  2009cites this paper
• Olive tree wood phenolic compounds with human platelet antiaggregant properties.

  2009cites this paper
• Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats.

  2009cites this paper
• Effect of 1-[4-[2-(4-Bromobenzenesulfonamino)ethyl]phenylsulfonyl]-3-(trans-4-methylcyclohexyl)urea (I4), a New Synthetic Sulfonylurea Compound, on Glucose Metabolism in vivo and in vitro

  2009cites this paper
• Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control

  2009cites this paper
• Collagen-induced p38 MAP kinase activation is a biomarker of platelet hyper-aggregation in patients with diabetes mellitus.

  2009cites this paper
• Effect of high glucose levels in human platelet NTPDase and 5'-nucleotidase activities.

  2008cites this paper
• Platelet signalling abnormalities in patients with type 2 diabetes mellitus: a review.

  2008influential citation
• Platelets count and Fibrinogen level with Type I and Type II Diabetes Mellitus Patients in Khartoum State

  2008cites this paper
• Thrombozytenfunktion bei Diabetes mellitus

  2008cites this paper
• The influence of antioxidants on thrombotic risk factors in healthy population

  2008influential citation
• Factor V Leiden G1691A and prothrombin gene G20210A mutations in patients with ischemic stroke and diabetes up to the age of 55

  2007cites this paper
• Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review.

  2007cites this paper
• Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat

  2007cites this paper
• CHAPTER 38 – Diabetes Mellitus

  2007cites this paper
• NTPDase and 5′-nucleotidase activities in platelets of human pregnants with a normal or high risk for thrombosis

  2007cites this paper
• Hemostatic Dysfunction Associated with Endocrine Disorders as a Major Risk Factor and Cause of Human Morbidity and Mortality: A Comprehensive Meta-review

  2007cites this paper
• Cinnamtannin B-1 from bay wood reduces abnormal intracellular Ca2+ homeostasis and platelet hyperaggregability in type 2 diabetes mellitus patients.

  2007cites this paper
• Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjects--a randomized double-blind placebo-controlled crossover study.

  2006cites this paper
• Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus

  2006cites this paper
• Thrombin generation in the evaluation of hypercoagulable state in type 1 diabetic patients with diabetic retinopathy and without this complication

  2006cites this paper
• ATIVIDADE DAS ENZIMAS NTPDASE E 5 - NUCLEOTIDASE EM PLAQUETAS DE GESTANTES NORMAIS E DE ALTO RISCO

  2006cites this paper
• UNIVERSIDADE FEDERAL DE SANTA MARIA CENTRO DE CIÊNCIAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS FARMACÊUTICAS

  2006cites this paper
• Platelet resistance to the anti-aggregating agents in the insulin resistant states.

  2006cites this paper
• Diabetes mellitus und das Gerinnungssystem

  2005cites this paper
• Short-term oral ingestion of Ginkgo biloba extract (EGb 761) reduces malondialdehyde levels in washed platelets of type 2 diabetic subjects.

  2005cites this paper
• Insensitivity to the α2-adrenergic receptor blocker yohimbine hydrochloride and occurrence of spontaneous platelet macroaggregation (SPMA) in diabetes

  2005cites this paper
• Insulin resistance does not impair contractile responses of cerebral arteries.

  2005cites this paper
• PLATELET FUNCTION IN DIABETES MELLITUS

  2005cites this paper
• Blood platelet reactivity and its pharmacological modulation in (people with) diabetes mellitus.

  2005cites this paper
• Hydrogen peroxide and peroxynitrite enhance Ca2+ mobilization and aggregation in platelets from type 2 diabetic patients.

  2005cites this paper
• Pathobiology and cell interactions of platelets in diabetes

  2005cites this paper
• Is aspirin effective in diabetic patients? Yes

  2005cites this paper
• Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.

  2005cites this paper
• Platelet activation in type 2 diabetes mellitus

  2004cites this paper
• Store-operated Ca2+ entry and tyrosine kinase pp60src hyperactivity are modulated by hyperglycemia in platelets from patients with non insulin-dependent diabetes mellitus

  2004cites this paper
• Red blood cell membrane mechanical fluctuations in non-proliferative and proliferate diabetic retinopathy

  2004cites this paper